Key result
Oral administration of the ACE2 activator DIZE for 4 weeks in 2K1C hypertensive rats attenuated renal dysfunction and reduced levels of inflammatory markers.
Why the study?
Very few studies have investigated the role of components of the counterregulatory RAS axis in renovascular hypertension, and the existing results remain controversial.
Does Diminazene Aceturate improve renal function and inflammation in a rat model of renovascular hypertension?
Does Diminazene Aceturate improve renal function and inflammation in a rat model of renovascular hypertension?
Answers are grounded in this paper and cite their sources.
In a rat model of renovascular hypertension, ACE2 activation with Diminazene Aceturate attenuated renal dysfunction and inflammation.
BACKGROUND: Angiotensin Converting Enzyme (ACE) 2 is an important modulator of the Renin Angiotensin System (RAS) and the RAS plays a central role in renovascular hypertension. Very few studies investigated the role of components of the counterregulatory RAS axis (ACE2, Ang-(1-7) and Mas receptor) in renovascular hypertension and the results are controversial. OBJECTIVE: The aim of this study was to investigate the effects of Diminazene Aceturate (DIZE) administration on renal function and renal inflammation parameters in 2K1C hypertensive rats. METHODS: Male Wistar rats were divided into three experimental groups: sham-operated animals, 2K1C+saline and 2K1C+DIZE orally (1 mg/kg/day). At the end of the 30 days of treatment, renal function was analyzed and kidneys from all the groups were collected and processed separately for measurement of N-acetyl-beta-D-glucosaminidase (NAG) and Myeloperoxidase (MPO) activities, cytokines, chemokines and nitric oxide levels. RESULTS: Oral DIZE administration for 4 weeks in hypertensive rats attenuated renal dysfunction and reduced the levels of MPO and NAG, cytokines and chemokines (IL1β, IL-6, TNF-α and MCP-1) and increased urinary nitrate/nitrite levels in 2K1C hypertensive rats. CONCLUSION: Our findings showed that ACE2 activation may effectively improve renal alterations and inflammation induced by renovascular hypertension.
No takes yet. Share an insight, caveat, or question.
Kangussu et al. (2019) studied Renovascular hypertension. Diminazene Aceturate (DIZE) vs. sham-operated animals and 2K1C+saline was evaluated on renal function and renal inflammation parameters. Oral administration of the ACE2 activator DIZE for 4 weeks in 2K1C hypertensive rats attenuated renal dysfunction and reduced levels of inflammatory markers.
Synapse has enriched 10 related papers. Consider them for comparative context: